Upon progression to AML, the VAF of the PTPN11 c.215C>T variant decreased, and two new PTPN11 variants (c.852T>C and c.182A>T) with high VAFs appeared, while the VAF of the EZH2 c.215C>T variant slightly increased. This evidence concerns the gene PTPN11 and acute myeloid leukemia.